Tirzepatide vs Semaglutide in Las Vegas:
How Providers Actually Decide
Choosing between tirzepatide and semaglutide comes down to your goals, medical history, budget, and how your body responds. Both produce significant weight loss. Tirzepatide typically delivers more; semaglutide is the established, more affordable starting point. At Body Balance Medical in Summerlin, we walk Las Vegas patients through this decision with an individualized medical evaluation — not trends or marketing claims.
Body Balance Medical is LegitScript-certified, which is why this page can name what we prescribe, what it costs, and how the two options actually differ. Most Las Vegas clinics advertising GLP-1 weight loss cannot make those disclosures clearly.
The Core Difference: One Receptor or Two
The fundamental difference between these two medications is how many hormone receptors each one targets.
Semaglutide is a GLP-1 receptor agonist. It mimics GLP-1, the hormone that regulates appetite and helps control blood sugar by slowing digestion and promoting fullness. This single-target approach has years of real-world data behind it for both weight management and diabetes care.
Tirzepatide targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. The GIP component is thought to enhance metabolic efficiency and improve how the body processes fat and energy — effects semaglutide's single-receptor action doesn't reach.
Both slow gastric emptying, reduce appetite, and require medical supervision for safe and effective results. Which one fits you depends on individual factors, not average trial numbers.
What the Head-to-Head Trial Actually Found
The SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, is the most direct comparison available — adults with obesity, without type 2 diabetes, tirzepatide against semaglutide.
| Outcome at 72 Weeks | Tirzepatide | Semaglutide |
|---|---|---|
| Average body weight reduction | 20.2% | 13.7% |
| Average absolute weight loss | ~50 lbs | ~33 lbs |
| Waist circumference reduction | 18.4 cm | 13.0 cm |
| Patients reaching ≥25% weight loss | 31.6% | 16.1% |
| Discontinuation rate | Slightly lower | Slightly higher |
Source: Aronne LJ et al. SURMOUNT-5 Trial. N Engl J Med. 2025;393(1):26–36. Trial averages under study conditions using FDA-approved formulations, not a prediction of individual results.
Two things worth pulling out of that table. First, the discontinuation rate was slightly lower with tirzepatide, which suggests tolerability at effective doses is comparable despite the stronger efficacy. Second, and less discussed: semaglutide's 13.7% is itself a clinically significant result. It is not a consolation prize.
Semaglutide also carries well-documented cardiovascular evidence. The SELECT trial showed roughly a 20% reduction in major cardiovascular events for patients with obesity — a dimension of value beyond weight loss that matters for some patients more than the larger weight number.
Side Effects: More Similar Than Different
Both medications produce primarily gastrointestinal side effects — nausea, vomiting, diarrhea, constipation, occasional abdominal discomfort — concentrated during dose escalation and typically easing as the body adjusts. Gradual titration under supervision is the main tool for managing them, and it works for both.
Both carry a Boxed Warning for possible increased risk of thyroid tumors, including medullary thyroid carcinoma, based on animal studies. Patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 are not candidates for either medication. A history of gallbladder disease, kidney disease, pancreatitis, or obstructive sleep apnea should be discussed with your provider before starting either.
At Body Balance Medical, provider oversight during dose escalation is built into both programs. Side effects that come up during titration get managed at your check-ins — not left for you to troubleshoot alone between shipments.
Cost: What Each Program Runs
Both are a real monthly investment, and for a lot of patients cost is the deciding factor rather than the trial data. Here is what each program costs at our Summerlin clinic, all-inclusive.
Medication, candidacy evaluation, dose titration, injection training, and ongoing provider check-ins. See the program →
Same all-inclusive structure, dual GIP/GLP-1 medication. See the program →
Both are flat-rate and cash-pay. No per-visit fees, no separate management charges, no insurance required. Compounded medications are generally not covered by insurance, which is why we price this way rather than sending you into a prior-authorization process with an uncertain outcome. HSA and FSA funds are generally accepted, and financing is available through Cherry and CareCredit.
The honest way to think about the $300 monthly difference: for patients who achieve substantially greater weight loss on tirzepatide, the cost per pound lost can favor the more expensive option. For patients who respond well to semaglutide, it doesn't. Nobody can tell you which group you're in before you start — which is the actual argument for supervised care with real check-ins rather than a subscription that never re-evaluates.
How the Programs Actually Run
Both medications are once-weekly subcutaneous injections — abdomen, thigh, or upper arm. Both require structured oversight to work properly. You'll get hands-on injection training at our Summerlin clinic so you're not learning from a video on your first night.
Semaglutide starts at 0.25mg weekly with gradual escalation based on your tolerance and response, with provider check-ins built in throughout. Tirzepatide follows the same structure starting at 2.5mg. Because tirzepatide has a dual mechanism and higher maximum doses, we monitor the escalation phase more closely to balance results against side effects.
Comprehensive lab work isn't always required to begin, but your provider determines what's appropriate based on your health history, current medications, and risk factors — and orders labs whenever they'd improve safety or clarify your plan.
How We Decide Which One Fits You
Seven factors go into the recommendation at your Medical Weight Loss Candidacy Evaluation:
Targeting 20% or more of body weight? Tirzepatide has stronger clinical potential. Looking for moderate, steady loss? Semaglutide delivers proven results at half the monthly cost.
Patients with cardiovascular concerns may favor semaglutide's more robust cardiovascular evidence base. Patients with type 2 diabetes may benefit from tirzepatide's stronger glycemic control.
Patients who have plateaued on semaglutide or another GLP-1 are often strong candidates for tirzepatide. Your history informs the starting point.
Semaglutide at $299/month is the more accessible entry point. Tirzepatide at $599/month is a larger commitment. Adherence over time matters more than the starting dose, so an honest budget conversation belongs at the front.
Some patients handle gastrointestinal effects more easily than others. Your history with GI sensitivity shapes both the choice and the titration pace.
Insulin sensitivity, diabetic retinopathy history, gallbladder disease, kidney function, and thyroid history all factor into which medication is appropriate and safe for you specifically.
Some patients want the longer track record and lower cost. Others want the most effective option regardless of price. Both are legitimate starting points.
Which One Should You Start With?
Proven Track Record.
Lower Entry Point.
- You want clinically proven effectiveness with years of real-world data
- You're starting your weight loss journey and want a balanced approach
- A lower monthly investment matters for long-term adherence
- You have cardiovascular concerns that align with semaglutide's evidence base
Maximum Results.
Dual Mechanism.
- You want the strongest clinically proven weight loss option available
- You've plateaued on semaglutide or another GLP-1
- Your goals involve 20%+ of body weight
- You have type 2 diabetes and want improved glycemic control alongside weight loss
Many patients start on semaglutide and move to tirzepatide if they plateau or want to accelerate. The programs are built to work as a progression, and switching is a normal clinical decision rather than a failure. Your provider guides that based on how you actually respond.
Getting Started in Las Vegas
Body Balance Medical is at 7975 W Sahara Ave #101 in Summerlin, minutes from the 215, serving patients across Las Vegas. Your Medical Weight Loss Candidacy Evaluation covers your medical history, your goals, and a straight answer on whether semaglutide, tirzepatide, or a different approach fits your situation.
We handle dose escalation, monitor for side effects, and adjust as you respond. A balanced diet and regular activity meaningfully improve results with either medication — our GLP-1 diet guide covers the practical nutrition side, particularly protein targets for preserving lean mass.
Common Questions
In the 2025 SURMOUNT-5 head-to-head trial, tirzepatide produced greater average weight loss — 20.2% versus 13.7% over 72 weeks — with slightly lower discontinuation rates, suggesting comparable tolerability.
For patients seeking maximum weight loss, tirzepatide is the stronger clinical option. That said, semaglutide's results are clinically significant in their own right, and it remains the appropriate choice for many patients based on goals, budget, and medical history.
At Body Balance Medical, Compounded Semaglutide is $299/month and Compounded Tirzepatide is $599/month, both all-inclusive — medication, provider oversight, dose titration, and check-ins, with no separate fees.
Patients already enrolled in hormone optimization may qualify for reduced pricing through The Balance Rate.
Yes, and it's common. Many patients start on semaglutide and transition if they plateau or want to accelerate results. Your provider manages the transition with attention to timing and dosing.
Starting on semaglutide is a clinically reasonable approach — it's a proven medication and the cost difference genuinely matters for staying on treatment long enough to see results.
Broadly yes — primarily gastrointestinal effects like nausea, diarrhea, and constipation during dose escalation. In SURMOUNT-5, discontinuation rates were slightly lower with tirzepatide.
Both carry a Boxed Warning regarding thyroid tumor risk based on animal studies. Gradual titration under medical supervision is the main tool for minimizing side effects with either medication.
Both were originally approved for type 2 diabetes before their weight loss indications. Tirzepatide's dual mechanism produces stronger glycemic control — the highest dose reduced HbA1c by a mean difference of 2% compared with semaglutide's 1.62% in clinical analysis.
For patients seeking both weight loss and improved blood sugar control, tirzepatide is generally the stronger option, subject to provider evaluation.
Body Balance Medical is a LegitScript-certified clinic at 7975 W Sahara Ave #101 in Summerlin, minutes from the 215. Both programs are prescribed and supervised on-site by our nurse practitioners.
Apply for a Medical Weight Loss Candidacy Evaluation and we'll review your history, walk through both options, and tell you which one we'd actually recommend for your situation.
It depends on your medical history, goals, budget, and clinical picture — assessed during a provider evaluation, not decided by a comparison article. This page exists to help you arrive at that conversation informed, not to make the decision for you.
Find Out Which Option
Fits Your Situation
Body Balance Medical offers Medical Weight Loss Candidacy Evaluations for patients across Las Vegas and Summerlin. We'll review your history, walk you through both options, and give you a straight answer.
Apply for Your EvaluationResults vary. Semaglutide and tirzepatide are prescription medications. Body Balance Medical prescribes compounded versions prepared by licensed compounding pharmacies. Compounded medications are not FDA-approved and are prescribed only after an individual clinical evaluation. Pricing is subject to change. This article is for informational purposes and does not constitute medical advice. All treatment decisions are made in consultation with a licensed medical provider. Body Balance Medical serves patients in Las Vegas and Summerlin, Nevada.